Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
Hyo Jin Kim, Ju-Yeon Cho, Yu Jin Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
Korean J Intern Med. 2015;30(1):32-41.   Published online 2014 Dec 30     DOI: https://doi.org/10.3904/kjim.2015.30.1.32
Citations to this article as recorded by Crossref logo
Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification
Jong Won Choi, Se Hyun Kim, Jeong Hun Seo, Yong Suk Cho, Sun Young Won, Byung Kyu Park, Han Ho Jeon, Yong Kang Lee, Chun Kyon Lee
Yonsei Medical Journal.2018; 59(3): 383.     CrossRef
Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea
Hyo Jun Ahn, Myeong Jun Song, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Haitao Guo
PLOS ONE.2017; 12(1): e0170362.     CrossRef
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
Gut and Liver.2017; 11(1): 129.     CrossRef
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues
Jing Zhou, Yue-Ying Liu, Jiang-Shan Lian, Li-Fang Pan, Jian-Le Yang, Jian-Rong Huang
Chinese Medical Journal.2017; 130(8): 914.     CrossRef
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clinical and Molecular Hepatology.2016; 22(2): 241.     CrossRef
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clinical and Molecular Hepatology.2016; 22(2): 238.     CrossRef
Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-Analysis
Hui-Lian Wang, Xi Lu, Xudong Yang, Nan Xu
Gastroenterology Research and Practice.2016; 2016: 1.     CrossRef
UPLC–MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients
Amedeo De Nicolò, Marco Simiele, Debora Pensi, Lucio Boglione, Sarah Allegra, Giovanni Di Perri, Antonio D’Avolio
Journal of Pharmaceutical and Biomedical Analysis.2015; 114: 127.     CrossRef
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Ji Hoon Kim, June Sung Lee
The Korean Journal of Internal Medicine.2015; 30(1): 23.     CrossRef
Tenofovir disoproxil fumarate
Reactions Weekly.2015; 1555(1): 186.     CrossRef